1. Home
  2. FMN vs ADVM Comparison

FMN vs ADVM Comparison

Compare FMN & ADVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FMN
  • ADVM
  • Stock Information
  • Founded
  • FMN 2002
  • ADVM 2006
  • Country
  • FMN United States
  • ADVM United States
  • Employees
  • FMN N/A
  • ADVM N/A
  • Industry
  • FMN Investment Managers
  • ADVM Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • FMN Finance
  • ADVM Health Care
  • Exchange
  • FMN Nasdaq
  • ADVM Nasdaq
  • Market Cap
  • FMN 86.2M
  • ADVM 98.0M
  • IPO Year
  • FMN N/A
  • ADVM 2014
  • Fundamental
  • Price
  • FMN $10.90
  • ADVM $4.26
  • Analyst Decision
  • FMN
  • ADVM Strong Buy
  • Analyst Count
  • FMN 0
  • ADVM 6
  • Target Price
  • FMN N/A
  • ADVM $27.83
  • AVG Volume (30 Days)
  • FMN 22.8K
  • ADVM 143.5K
  • Earning Date
  • FMN 01-01-0001
  • ADVM 05-08-2025
  • Dividend Yield
  • FMN 3.86%
  • ADVM N/A
  • EPS Growth
  • FMN N/A
  • ADVM N/A
  • EPS
  • FMN N/A
  • ADVM N/A
  • Revenue
  • FMN N/A
  • ADVM $1,000,000.00
  • Revenue This Year
  • FMN N/A
  • ADVM N/A
  • Revenue Next Year
  • FMN N/A
  • ADVM $1,162.55
  • P/E Ratio
  • FMN N/A
  • ADVM N/A
  • Revenue Growth
  • FMN N/A
  • ADVM N/A
  • 52 Week Low
  • FMN $9.09
  • ADVM $3.52
  • 52 Week High
  • FMN $11.31
  • ADVM $14.16
  • Technical
  • Relative Strength Index (RSI)
  • FMN 44.81
  • ADVM 44.68
  • Support Level
  • FMN $10.77
  • ADVM $4.76
  • Resistance Level
  • FMN $11.00
  • ADVM $5.23
  • Average True Range (ATR)
  • FMN 0.07
  • ADVM 0.51
  • MACD
  • FMN 0.00
  • ADVM -0.12
  • Stochastic Oscillator
  • FMN 56.52
  • ADVM 24.69

About FMN Federated Hermes Premier Municipal Income Fund

Federated Hermes Premier Municipal Income Fund is a United States-based diversified, closed-end management investment company. The investment objective of the fund is to provide current income exempt from federal income tax, including the federal alternative minimum tax by investing in long-term, tax exempt municipal bonds diversified among states, sectors and issuers. Its portfolio of investments comprises different sectors such as hospitals, toll road, senior care, airport, tobacco, and other sectors.

About ADVM Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc is a U.S.-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company primarily generates revenue through license, research and collaboration arrangements with its strategic partners. Its lead product candidate is ADVM-022 which is a single, in-office intravitreal (IVT) injection gene therapy designed to deliver long-term durable levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with frequent anti-vascular endothelial growth factor (VEGF) injections. It has one segment developing and commercializing gene therapeutics.

Share on Social Networks: